Enasidenib in mIDH relapsed and refractory AML

Safety and efficacy of blinatumomab for acute lymphoblastic leukaemia

TGR-1202, ublituximab and ibrutinib combination for advanced CLL and NHL

ESMO ranking of the clinical benefits of new drugs

Gastrectomy and oral drug prescription

Stereotactic radiotherapy in primary hepatic cancer

(6/6) ASCO 2017: Round up of expert discussion on the latest in prostate cancer

(5/6) ASCO 2017: ASCO highlights in prostate cancer

(4/6) ASCO 2017: Expert discussion on the latest in prostate cancer

(3/6) ASCO 2017: STAMPEDE data

(2/6) ASCO 2017: LATITUDE data

(1/6) ASCO 2017: Introduction to Expert discussion on the latest in prostate cancer